GHR Foundation
Established in 1965, GHR Foundation is a U.S.-based non-profit organization dedicated to fostering transformational changes in education, health, and global development. It aims to promote equity, dignity, and care worldwide through its support for initiatives focused on preventing Alzheimer's Disease and related dementias, cultivating an inclusive global Catholic Church, and enhancing financial empowerment and educational excellence in Minneapolis and St. Paul.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
7 past transactions
Atalanta Therapeutics
Series B in 2025
Atalanta Therapeutics is a biotechnology company developing targeted RNA-modulating therapeutics for treating genetically defined diseases. It utilizes proprietary structure-switching molecules to modulate gene expression, focusing on oncology, neurology, and rare genetic disorders.
C2N Diagnostics
Grant in 2024
Founded in 2007 by scientists from Washington University School of Medicine and LifeTech Research, C2N Diagnostics specializes in protein diagnostic testing services for neurological disorders. Utilizing mass spectrometry-based analysis, the company aims to provide accurate and sensitive diagnostics for conditions like Alzheimer's disease.
Horizon Next
Grant in 2023
Nowadays AI, Robots and automation are trend, but very soon autonomous devices, car and other machines will be everywhere at our daily life. From our over the horizon vision, "Horizon Next" team is bringing innovation to life, aiming equal and wealth life for humans.
C2N Diagnostics
Venture Round in 2023
Founded in 2007 by scientists from Washington University School of Medicine and LifeTech Research, C2N Diagnostics specializes in protein diagnostic testing services for neurological disorders. Utilizing mass spectrometry-based analysis, the company aims to provide accurate and sensitive diagnostics for conditions like Alzheimer's disease.
Braille Teach
Grant in 2022
Braille Teach is a device with audio feedback to help blind and visually impaired people learn the Braille alphabet.
Horizon Next
Grant in 2022
Nowadays AI, Robots and automation are trend, but very soon autonomous devices, car and other machines will be everywhere at our daily life. From our over the horizon vision, "Horizon Next" team is bringing innovation to life, aiming equal and wealth life for humans.
C2N Diagnostics
Grant in 2020
Founded in 2007 by scientists from Washington University School of Medicine and LifeTech Research, C2N Diagnostics specializes in protein diagnostic testing services for neurological disorders. Utilizing mass spectrometry-based analysis, the company aims to provide accurate and sensitive diagnostics for conditions like Alzheimer's disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.